Literature DB >> 25554612

Accumulation of abdominal fat in relation to selected proinflammatory cytokines concentrations in non-obese Wrocław inhabitants.

Grażyna Bednarek-Tupikowska, Aleksandra Zdrojowy-Wełna1, Barbara Stachowska, Justyna Kuliczkowska-Płaksej, Magdalena Matczak-Giemza, Eliza Kubicka, Urszula Tworowska-Bardzińska, Andrzej Milewicz, Marek Bolanowski.   

Abstract

INTRODUCTION: Metabolically obese normal weight (MONW) subjects, despite their normal BMI, present metabolic disturbances characteristic of abdominal obesity. One of the reasons might be subclinical inflammation caused by the fat tissue excess. The aim of this study was to assess the association between the accumulation of fat (especially abdominal) and the concentration of selected proinflammatory cytokines - interleukins (IL-6, IL-18) and C-reactive protein (CRP).
MATERIAL AND METHODS: The study population consisted of 342 subjects (218 women, 124 men; age 20-40 years, BMI < 27 kg/m2) recruited from a community centre in Wroclaw. The group was divided based on the homeostasis assessment insulin resistance index (HOMA) value: 90 MONW subjects with HOMA > 1.69 and 252 subjects as control group. Anthropometric parameters, serum IL-6, IL-18, CRP, glucose, insulin concentrations and insulin sensitivity/resistance indexes were evaluated.
RESULTS: CRP levels were significantly higher (3.26 vs. 1.97, p = 0.03) in MONW women than in the control group. Serum IL-6, IL-18 levels in males and females did not differ in both groups. IL-6 showed a significant correlation with the abdominal to gynoidal fat tissue deposit ratio in women. There were correlations between the CRP and BMI, WHR, waist circumference, total fat, abdominal fat deposit, and abdominal to gynoidal fat deposit ratio in both sexes. In women, positive correlations between CRP and HOMA, FIRI and negative with QUICKI index were present.
CONCLUSIONS: Increased accumulation of abdominal adipose tissue in non-obese, young and healthy subjects is related to increased CRP levels.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25554612     DOI: 10.5603/EP.2014.0062

Source DB:  PubMed          Journal:  Endokrynol Pol        ISSN: 0423-104X            Impact factor:   1.582


  6 in total

1.  Metabolic health and weight: Understanding metabolically unhealthy normal weight or metabolically healthy obese patients.

Authors:  Hannah Mathew; Olivia M Farr; Christos S Mantzoros
Journal:  Metabolism       Date:  2015-10-23       Impact factor: 8.694

2.  The Need for SPACE to Plan the Future for Spondyloarthritis.

Authors:  Mark Hwang; Michael H Weisman
Journal:  J Rheumatol       Date:  2021-12-15       Impact factor: 5.346

Review 3.  New obesity classification criteria as a tool for bariatric surgery indication.

Authors:  Antonino De Lorenzo; Laura Soldati; Francesca Sarlo; Menotti Calvani; Nicola Di Lorenzo; Laura Di Renzo
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

4.  Does body mass index (BMI) influence the Ankylosing Spondylitis Disease Activity Score in axial spondyloarthritis?: Data from the SPACE cohort.

Authors:  Roxana Rubio Vargas; Rosaline van den Berg; Miranda van Lunteren; Zineb Ez-Zaitouni; Pauline A C Bakker; Hanne Dagfinrud; Roberta Ramonda; Robert Landewé; Esmeralda Molenaar; Floris A van Gaalen; Désirée van der Heijde
Journal:  RMD Open       Date:  2016-06-16

Review 5.  Cancer Risk in Normal Weight Individuals with Metabolic Obesity: A Narrative Review.

Authors:  Bethina Liu; Hugh E Giffney; Rhonda S Arthur; Thomas E Rohan; Andrew J Dannenberg
Journal:  Cancer Prev Res (Phila)       Date:  2021-02-09

6.  Short-Term Combined Exercise Improves Inflammatory Profile in the Retina of Obese Mice.

Authors:  Thaís Dantis Pereira de Campos; Kellen Cristina da Cruz Rodrigues; Rodrigo Martins Pereira; Ana Paula Morelli; Alisson Luiz da Rocha; Raphael Dos Santos Canciglieri; Adelino Sanchez Ramos da Silva; Eduardo Rochete Ropelle; José Rodrigo Pauli; Fernando Moreira Simabuco; Dennys Esper Cintra; Leandro Pereira de Moura
Journal:  Int J Mol Sci       Date:  2020-08-24       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.